Tower Research Capital (TRC)’s UpHealth, Inc. UPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-7,089
Closed -$6.95K 6407
2023
Q3
$6.95K Buy
7,089
+1,376
+24% +$2.01K ﹤0.01% 4534
2023
Q2
$10.7K Buy
5,713
+1,143
+25% +$1.89K ﹤0.01% 4072
2023
Q1
$7K Buy
4,570
+1,129
+33% +$2.49K ﹤0.01% 4811
2022
Q4
$6K Buy
+3,441
New +$13.4K ﹤0.01% 4813
2022
Q3
Sell
-1,487
Closed -$9K 6852
2022
Q2
$9K Buy
1,487
+820
+123% +$6.38K ﹤0.01% 4629
2022
Q1
$8K Buy
+667
New +$14.8K ﹤0.01% 4658
2021
Q4
Sell
-823
Closed -$26K 6890
2021
Q3
$26K Buy
823
+798
+3,192% +$41.7K ﹤0.01% 3502
2021
Q2
$2K Sell
25
-15
-38% -$1.41K ﹤0.01% 5122
2021
Q1
$4K Sell
40
-347
-90% -$35.9K ﹤0.01% 4843
2020
Q4
$42K Buy
387
+276
+249% +$28.4K ﹤0.01% 3288
2020
Q3
$11K Buy
111
+56
+102% +$5.71K ﹤0.01% 4078
2020
Q2
$6K Buy
+55
New +$5.51K ﹤0.01% 4243

Other funds holding UPH

Tower Research Capital (TRC)'s UPH Position: Q4 2023 in Review

Tower Research Capital (TRC) sold out of UpHealth, Inc. (UPH) in Q4 2023, closing a stake of 7,089 shares — an estimated $6.95K sold.

Tower Research Capital (TRC) first reported a position in UPH in Q2 2020 and held it in 12 quarters. The position peaked at $42K in Q4 2020. 5 funds tracked by Wall St. Rank hold UPH as of Q4 2023.

  • Tower Research Capital (TRC) reported no remaining UpHealth, Inc. position as of Q4 2023 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 7,089 UpHealth, Inc. shares in Q4 2023, an estimated $6.95K.
  • Tower Research Capital (TRC) first reported a position in UpHealth, Inc. in Q2 2020 and held it in 12 quarters.
  • Tower Research Capital (TRC)'s UpHealth, Inc. position peaked at $42K in Q4 2020.
  • 5 funds tracked by Wall St. Rank held UpHealth, Inc. as of Q4 2023.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2023, filed 13 Feb 2024.